Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. 8481475 1993
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE In addition, ten examples of endometrial carcinoma were evaluated for VPE/VEGF protein expression by immunohistochemistry. 8697391 1996
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Messenger RNA encoding VEGF was detected in all tissues studied and was more densely expressed in endometrial carcinoma. 9032563 1996
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma. 8626126 1996
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers. 10381125 1998
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE The induction of VEGF by progestins is also cell type specific and does not occur in human breast cancer cell lines MCF-7, ZR-75, or MDA-MB-231, nor in Ishikawa cells derived from a human endometrial carcinoma. 9458078 1998
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE VEGF and TP may cooperatively promote angiogenesis in endometrial cancer, but these expressions may have limited additional prognostic value. 10468067 1999
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins. 10816575 2000
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Therefore, insulin could contribute to the increased risk of endometrial carcinoma due to its ability to induce VEGF expression and thus participate in the maintenance of an angiogenic phenotype. 11232025 2001
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE COX-2 is upregulated in endometrial cancer and facilitates tumor growth via angiogenesis produced in associated with VEGF and TP. 11957147 2002
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE In this study, we aimed to study VEGF expression in endometrial carcinoma cells and the effect of p53 gene transfection on VEGF expression using p53-mutated endometrial carcinoma cell line, HEC-50B. 12971625 2003
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE VEGF expression was downregulated by p53 in endometrial carcinoma cells. 12782015 2003
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer. 12942123 2003
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE A strong expression of VEGF-A mRNA was significantly seen in carcinosarcomas compared to high-grade endometrial carcinomas. 15581949 2004
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Sex steroid-dependent VEGF and TP are highly expressed in cases of early stage and well-differentiated uterine endometrial cancers, and basic fibroblast growth factor (bFGF) in cases of advanced and poorly differentiated uterine endometrial cancers. 15860258 2005
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE Further work is needed to establish if IGF-1 plays a role in a subset of endometrial cancers and if isoforms of VEGF play a role in endometrial cancer. 15917160 2005
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE Estrogen receptors alpha and beta regulate production of VEGF in both breast and endometrial cancer cells. 16267616 2006
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 GeneticVariation disease BEFREE The present study is the first case-control study of VEGF and ANGPT-2 polymorphisms in relation to ovarian, cervical, and endometrial cancers. 17630849 2007
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease CTD_human The aim of this study is to investigate the angiogenetic process by determining the levels of vascular endothelial growth factor (VEGF), monocyte chemoattractant protein (MCP)-1 and interleukin (IL)-8 in endometrial cancer cells and to study the effect of nimesulide, a selective COX-2 inhibitor, on these mediators using cell culture. 17380299 2007
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells. 19148513 2009
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE To test the hypothesis that restoring HIF-1alpha in cultured cells would restore the ability of E(2) to induce VEGF expression, we treated human endometrial cancer cells (ECC-1) with cobalt chloride (CoCl(2);100 microm), which prevents oxygen-induced HIF-1alpha degradation. 19819950 2009
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Expression of VEGF mRNA in the groups of EC and atypical hyperplasia (AH) was significantly increased in comparison with the groups of NE (P<0.05). 20127022 2010
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells. 22057922 2011
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 AlteredExpression disease BEFREE The mutant stroma cells also had higher levels of vascular endothelial growth factor and stromal derived factor signaling components and diminished expression of estrogen receptor α and progesterone receptor, which is common in advanced stages of human endometrial cancer and is an indicator of poor prognosis. 21363919 2011
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.400 Biomarker disease BEFREE Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades. 22178239 2012